SLE initially presenting with neuropsychiatric manifestations and seizure, case report

© 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd..

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder exhibiting variable disease courses and multiple clinical manifestations. SLE's aetiology remains unclear; however, different environmental (e.g., ultraviolet light, infections, drugs, etc.), genetic, and hormonal factors are potentially involved. A positive family history and history of having other autoimmune illnesses are considered high-risk factors for SLE; nevertheless, most SLE cases are scattered. The 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for SLE include at least one positive antinuclear antibody test as a mandatory entry criterion, followed by additive weighted standards grouped in seven clinical (constitutional, haematological, neuropsychiatric, serosal, musculoskeletal, renal, and mucocutaneous) and three immunological (antiphospholipid antibodies, complement proteins, and SLE-specific antibodies) domains weighted from 2 to 10, with patients accumulating ≥10 points being diagnosed with SLE. Herein, we report a case of neuropsychiatric lupus, a rare and severe form of SLE.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Immunity, inflammation and disease - 11(2023), 6 vom: 20. Juni, Seite e918

Sprache:

Englisch

Beteiligte Personen:

Khormi, Abdulrahman Ali M [VerfasserIn]
Hijazi, Faisal Taher [VerfasserIn]

Links:

Volltext

Themen:

Antibodies
Autoimmunity
Blood
Case Reports
Diseases
Journal Article
Systemic lupus erythematosus
Tissues

Anmerkungen:

Date Completed 30.06.2023

Date Revised 02.07.2023

published: Print

Citation Status MEDLINE

doi:

10.1002/iid3.918

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM35883550X